VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2015 | Treating mantle cell lymphoma earlier in the disease course

At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses the movement towards utilizing novel therapeutic agents earlier in the disease course of mantle cell lymphoma.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter